Brain atrophy in patients on peritoneal dialysis treatment

Affiliations

Editorial

Tetsu Akimoto. Hypertens Res. 2024 Apr.

. 2024 Apr;47(4):981-983.

doi: 10.1038/s41440-023-01565-8. Epub 2024 Jan 5.

¹ Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Tochigi, Japan. tetsu-a@jichi.ac.jp.

No abstract available

Keywords: Brain atrophy; Cognitive impairment; Peritoneal dialysis.

Comment on

More rapid progression of brain atrophy in patients on peritoneal dialysis compared with hemodialysis: The VCOHP Study.
Tsuruya K, Yoshida H, Yamada S, Haruyama N, Tanaka S, Tsuchimoto A, Eriguchi M, Fujisaki K, Torisu K, Nakano T, Masutani K, Kitazono T. Tsuruya K, et al. Hypertens Res. 2024 Apr;47(4):887-897. doi: 10.1038/s41440-023-01530-5. Epub 2023 Dec 20. Hypertens Res. 2024. PMID: 38123712

1. Tian X, Guo X, Xia X, Yu H, Li X, Jiang A. The comparison of cognitive function and risk of dementia in CKD patients under peritoneal dialysis and hemodialysis: a PRISMA-compliant systematic review and meta-analysis. Medicine. 2019;98:e14390. - DOI - PubMed - PMC
1. O’Lone E, Connors M, Masson P, Wu S, Kelly PJ, Gillespie D, et al. Cognition in people with end-stage kidney disease treated with hemodialysis: a systematic review and meta-analysis. Am J Kidney Dis. 2016;67:925–35. - DOI - PubMed
1. Wolfgram DF, Szabo A, Murray AM, Whittle J. Risk of dementia in peritoneal dialysis patients compared with hemodialysis patients. Perit Dial Int. 2015;35:189–98. - DOI - PubMed - PMC
1. Tsuruya K, Yoshida H, Haruyama N, Fujisaki K, Hirakata H, Kitazono T. Clinical significance of fronto-temporal gray matter atrophy in executive dysfunction in patients with chronic kidney disease: the VCOHP study. PLoS ONE. 2015;10:e0143706. - DOI - PubMed - PMC
1. Tsuruya K, Yoshida H. Brain atrophy and cognitive impairment in chronic kidney disease. Contrib Nephrol. 2018;196:27–36. - DOI - PubMed